← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Terpenoid Therapeutics, Inc.
Coralville, IA
$1,720,874
Total funding
7
Grants
Funding over time
peak $655.4K · FY2007–14$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,720,874 · 7
By mechanism
R42$782,917 · 1
R43$482,093 · 3
R41$455,864 · 3
Investigators at Terpenoid Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Developing Schweinfurthin Analogs as Glioma Therapies$338,914
R42 · FY2010 · NS
Developing Schweinfurthin Analogs as Glioma Therapies$331,503
R42 · FY2009 · NS
Targeting the chondrosarcoma extracellular matrix for drug delivery$222,881
R41 · FY2014 · CA
Schweinfurthins: novel treatment for breast cancer$204,000
R43 · FY2010 · CA
Feasibility study of GGDPS inhibition for osteoporosis$163,134
R43 · FY2013 · AG
Preclinical Development of Geranylgeranyl Disphosphate Synthase Inhibitors as Ant$123,123
R41 · FY2007 · CA
Improving the Distribution of Geranylgeranyl Diphosphate synthase inhibitors.$114,959
R43 · FY2009 · CA
Developing Schweinfurthin Analogs as Glioma Therapies$112,500
R42 · FY2010 · NS
Novel Glioblastoma Therapeutics$109,860
R41 · FY2007 · CA